A better insight into the relationship between checkpoint HLA-G and cytokines is to more effectively implement these tumour immunotherapy approaches, including anti-HLA-G neutralising antibodies and anti-HLA-G CAR-T cells (Carosella et al. 2021). Here, HLA-G is linked to neoplasm.